Publications

Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.

Kabata H, Artis D.  2019.  Neuro-immune crosstalk and allergic inflammation.. J Clin Invest. 130:1475-1482.

Chu C, Artis D, Chiu IM.  2020.  Neuro-immune Interactions in the Tissues.. Immunity. 52(3):464-474.

Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S.  2023.  Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.. J Allergy Clin Immunol.

Yano H, Artis D.  2022.  Neuronal regulation of innate lymphoid cell responses.. Curr Opin Immunol. 76:102205.

Klose CSn, Artis D.  2019.  Neuronal regulation of innate lymphoid cells.. Curr Opin Immunol. 56:94-99.

Veiga-Fernandes H, Artis D.  2018.  Neuronal-immune system cross-talk in homeostasis.. Science. 359(6383):1465-1466.

Nagashima H, Mahlakõiv T, Shih H-Y, Davis FP, Meylan F, Huang Y, Harrison OJ, Yao C, Mikami Y, Urban JF et al..  2019.  Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.. Immunity.

Klose CSN, Mahlakõiv T, Moeller JB, Rankin LC, Flamar A-L, Kabata H, Monticelli LA, Moriyama S, Putzel GGarbès, Rakhilin N et al..  2017.  The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.. Nature. 549(7671):282-286.

Wallrapp A, Riesenfeld SJ, Burkett PR, Abdulnour R-EE, Nyman J, Dionne D, Hofree M, Cuoco MS, Rodman C, Farouq D et al..  2017.  The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.. Nature. 549(7672):351-356.

Tsou AM, Yano H, Parkhurst CN, Mahlakõiv T, Chu C, Zhang W, He Z, Jarick KJ, Zhong C, Putzel GG et al..  2022.  Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.. Nature. 611(7937):787-793.

J Blander M.  2019.  A new approach for inflammatory bowel disease therapy.. Nat Med. 25(4):545-546.

Linehan JL, Harrison OJ, Han S-J, Byrd AL, Vujkovic-Cvijin I, Villarino AV, Sen SK, Shaik J, Smelkinson M, Tamoutounour S et al..  2018.  Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair.. Cell. 172(4):784-796.e18.

Jarick KJ, Topczewska PM, Jakob MO, Yano H, Arifuzzaman M, Gao X, Boulekou S, Stokic-Trtica V, Leclère PS, Preußer A et al..  2022.  Non-redundant functions of group 2 innate lymphoid cells.. Nature. 611(7937):794-800.

Chen K-Y, Srinivasan T, Tung K-L, Belmonte JM, Wang L, Murthy PKadur Laks, Choi J, Rakhilin N, King S, Varanko AKristine et al..  2017.  A Notch positive feedback in the intestinal stem cell niche is essential for stem cell self-renewal.. Mol Syst Biol. 13(4):927.

Srinivasan T, Walters J, Bu P, Than EBich, Tung K-L, Chen K-Y, Panarelli N, Milsom J, Augenlicht L, Lipkin SM et al..  2016.  NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer-Initiating Cells.. Cancer Res. 76(11):3411-21.

Srinivasan T, Than EBich, Bu P, Tung K-L, Chen K-Y, Augenlicht L, Lipkin SM, Shen X.  2016.  Notch signalling regulates asymmetric division and inter-conversion between lgr5 and bmi1 expressing intestinal stem cells.. Sci Rep. 6:26069.

Sonnenberg GF, Artis D.  2019.  Novel connections and precision approaches.. Nat Rev Immunol. 19(2):75-76.

Waller RG, Darlington TM, Wei X, Madsen MJ, Thomas A, Curtin K, Coon H, Rajamanickam V, Musinsky J, Jayabalan D et al..  2018.  Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk.. PLoS Genet. 14(2):e1007111.

Arifuzzaman M, Collins N, Guo C-J, Artis D.  2024.  Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation.. Immunity. 57(1):14-27.

Kivolowitz C, Abdulhamid A, Victorio D, Castellanos J, Simpson K, Scherl E, Longman RS.  2016.  O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity.. Inflamm Bowel Dis. 22 Suppl 1:S3.

Hill DA, Siracusa MC, Ruymann KR, Wojno EDTait, Artis D, Spergel JM.  2014.  Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children.. Allergy. 69(5):674-7.

Pascutti MFernanda, Geerman S, Collins N, Brasser G, Nota B, Stark R, Behr F, Oja A, Slot E, Panagioti E et al..  2019.  Peripheral and systemic antigens elicit an expandable pool of resident memory CD8+ T cells in the bone marrow.. Eur J Immunol. 49(6):853-872.

Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen W-P, Mo A, Tucker C, Bhattacharya A et al..  2015.  A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.. Cancer Prev Res (Phila). 8(3):222-30.

Goodenberger MKL, Thomas BC, Riegert-Johnson D, C Boland R, Plon SE, Clendenning M, Win AKo, Senter L, Lipkin SM, Stadler ZK et al..  2016.  PMS2 monoallelic mutation carriers: the known unknown.. Genet Med. 18(1):13-9.